Accessing antiretroviral therapy following release from prison.

CONTEXT Interruption of antiretroviral therapy (ART) during the first weeks after release from prison may increase risk for adverse clinical outcomes, transmission of human immunodeficiency virus (HIV), and drug-resistant HIV reservoirs in the community. The extent to which HIV-infected inmates experience ART interruption following release from prison is unknown. OBJECTIVES To determine the proportion of inmates who filled an ART prescription within 60 days after release from prison and to examine predictors of this outcome. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of all 2115 HIV-infected inmates released from the Texas Department of Criminal Justice prison system between January 2004 and December 2007 and who were receiving ART before release. MAIN OUTCOME MEASURE Proportion of inmates who filled an ART prescription within 10, 30, and 60 days of release from prison. RESULTS Among the entire study cohort (N = 2115), an initial prescription for ART was filled by 115 (5.4%) inmates within 10 days of release (95% confidence interval [CI], 4.5%-6.5%), by 375 (17.7%) within 30 days (95% CI, 16.2%-19.4%), and by 634 (30.0%) within 60 days (95% CI, 28.1%-32.0%). In a multivariate analysis of predictors (including sex, age, race/ethnicity, viral load, duration of ART, year of discharge, duration of incarceration, parole, and AIDS Drug Assistance Program application assistance), Hispanic and African American inmates were less likely to fill a prescription within 10 days (adjusted estimated risk ratio [RR], 0.4 [95% CI, 0.2-0.8] and 0.4 [95% CI, 0.3-0.7], respectively) and 30 days (adjusted estimated RR, 0.7 [95% CI, 0.5-0.9] and 0.7 [95% CI, 0.5-0.9]). Inmates with an undetectable viral load were more likely to fill a prescription within 10 days (adjusted estimated RR, 1.8 [95% CI, 1.2-2.7]), 30 days (1.5 [95% CI, 1.2-1.8]), and 60 days (1.3 [95% CI, 1.1-1.5]). Inmates released on parole were more likely to fill a prescription within 30 days (adjusted estimated RR, 1.3 [95% CI, 1.1-1.6]) and 60 days (1.5 [95% CI, 1.4-1.7]). Inmates who received assistance completing a Texas AIDS Drug Assistance Program application were more likely to fill a prescription within 10 days (adjusted estimated RR, 3.1 [95% CI, 2.0-4.9]), 30 days (1.8 [95% CI, 1.4-2.2]), and 60 days (1.3 [95% CI, 1.1-1.4]). CONCLUSION Only a small percentage of Texas prison inmates receiving ART while incarcerated filled an initial ART prescription within 60 days of their release.

[1]  Leach,et al.  Antiretroviral prescribing patterns in the texas prison system. , 2000, Annals of epidemiology.

[2]  J. Zhang,et al.  What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. , 1998, JAMA.

[3]  A. McMillan.  HIV in prisons. , 1988, BMJ.

[4]  L. Rabeneck,et al.  Utilization of health care resources by HIV-infected white, African-American, and Hispanic men in the era before highly active antiretroviral therapy. , 2003, Journal of the National Medical Association.

[5]  J. Margolick,et al.  Interruption and Discontinuation of Highly Active Antiretroviral Therapy in the Multicenter AIDS Cohort Study , 2005, Journal of acquired immune deficiency syndromes.

[6]  R. Hogg,et al.  Initiating Highly Active Antiretroviral Therapy and Continuity of HIV Care: The Impact of Incarceration and Prison Release on Adherence and HIV Treatment Outcomes , 2003, Antiviral therapy.

[7]  A. Margolis,et al.  Predictors of risky sex of young men after release from prison , 2003, International journal of STD & AIDS.

[8]  J Darbyshire,et al.  CD4+ count-guided interruption of antiretroviral treatment. , 2006, The New England journal of medicine.

[9]  M. Wainberg,et al.  Public health implications of antiretroviral therapy and HIV drug resistance. , 1998, JAMA.

[10]  T. Flanigan,et al.  Infection with the human immunodeficiency virus in prisoners: meeting the health care challenge. , 1993, The American journal of medicine.

[11]  J. Rich,et al.  HIV infection behind bars. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  R. Hogg,et al.  Nonadherence to Antiretroviral Therapy Among a Community With Endemic Rates of Injection Drug Use , 2005, Journal of the International Association of Physicians in AIDS Care.

[13]  F. Altice,et al.  Effectiveness of antiretroviral therapy among HIV-infected prisoners: reincarceration and the lack of sustained benefit after release to the community. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  V. Soriano,et al.  Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. , 1999, AIDS.

[15]  R. Frankowski,et al.  Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure , 2005, AIDS care.

[16]  J. Pryor,et al.  Stigma, Secrecy, and Discrimination: Ethnic/Racial Differences in the Concerns of People Living with HIV/AIDS , 2008, AIDS and Behavior.

[17]  J. Rich,et al.  Successful linkage of medical care and community services for HIV-positive offenders being released from prison , 2001, Journal of Urban Health.

[18]  Matthias Cavassini,et al.  Correlates of Self-Reported Nonadherence to Antiretroviral Therapy in HIV-Infected Patients: The Swiss HIV Cohort Study , 2006, Journal of acquired immune deficiency syndromes.

[19]  Christy A. Visher,et al.  Health and Prisoner Reentry: How Physical, Mental, and Substance Abuse Conditions Shape the Process of Reintegration , 2008 .

[20]  D. Bloch,et al.  A simple method of sample size calculation for linear and logistic regression. , 1998, Statistics in medicine.

[21]  M. Wolf,et al.  Social stigma concerns and HIV medication adherence. , 2006, AIDS patient care and STDs.

[22]  S. Holmberg,et al.  Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care , 2005, AIDS.

[23]  F. Mostashari,et al.  Trust and the Acceptance of and Adherence to Antiretroviral Therapy , 2001, Journal of acquired immune deficiency syndromes.

[24]  W. Miller,et al.  Psychiatric Illness and Virologic Response in Patients Initiating Highly Active Antiretroviral Therapy , 2007, Journal of acquired immune deficiency syndromes.

[25]  I. Binswanger,et al.  Psychiatric disorders and repeat incarcerations: the revolving prison door. , 2009, The American journal of psychiatry.

[26]  H. Palacio,et al.  Effect of Race and/or Ethnicity in Use of Antiretrovirals and Prophylaxis for Opportunistic Infection: A Review of the Literature , 2002, Public health reports.

[27]  A. Kaplan,et al.  Effect of Release from Prison and Re-Incarceration on the Viral Loads of HIV-Infected Individuals , 2005, Public health reports.

[28]  H. Palacio,et al.  Access to and Use of HIV Antiretroviral Therapy: Variation by Race/Ethnicity in Two Public Insurance Programs in the U.S. , 2002, Public health reports.

[29]  V. Derlega,et al.  AIDS stigma among inmates and staff in a USA state prison , 2008, International journal of STD & AIDS.

[30]  J. Stobo,et al.  Health care delivery in the Texas prison system: the role of academic medicine. , 2004, JAMA.

[31]  B. Thiers,et al.  CD4+ Count–Guided Interruption of Antiretroviral Treatment , 2007 .

[32]  O. Grinstead,et al.  HIV, STD, and Hepatitis Risk in the Week Following Release From Prison: An Event-Level Analysis , 2007 .

[33]  Christopher J. Mumola.  Substance Abuse and Treatment, State and Federal Prisoners, 1997: (377902004-001) , 1999 .

[34]  J. Elmore,et al.  Release from prison--a high risk of death for former inmates. , 2007, The New England journal of medicine.

[35]  Gary G. Koch,et al.  Categorical Data Analysis Using The SAS1 System , 1995 .

[36]  J. J. Henning,et al.  Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000 , 1998, HIV clinical trials.